These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 9382086)
1. Message therapy: gene therapy that targets mRNA sequence and stability. Kozarsky KF; Couture LA Am J Hum Genet; 1997 Oct; 61(4):790-4. PubMed ID: 9382086 [No Abstract] [Full Text] [Related]
2. Making sense of antisense. Murakami A Trends Mol Med; 2001 Oct; 7(10):430-1. PubMed ID: 11597507 [No Abstract] [Full Text] [Related]
3. [The significance of specific oligonucleotides in clinical medicine and their use in the treatment of patients with infective diseases]. Bojić I Vojnosanit Pregl; 1996; 53(5):399-408. PubMed ID: 9229959 [No Abstract] [Full Text] [Related]
4. Therapeutic antisense and ribozymes. Rossi JJ Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645 [TBL] [Abstract][Full Text] [Related]
6. [Progress of gene therapy in pancreatic carcinoma]. Liang Z; Liu T Zhonghua Bing Li Xue Za Zhi; 2002 Dec; 31(6):548-50. PubMed ID: 12760344 [No Abstract] [Full Text] [Related]
7. Gene therapy for HIV. Lever AM Sex Transm Infect; 2001 Apr; 77(2):93-6. PubMed ID: 11287684 [No Abstract] [Full Text] [Related]
8. Antisense oligonucleotides as therapeutic agents. Alama A; Barbieri F; Cagnoli M; Schettini G Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660 [TBL] [Abstract][Full Text] [Related]
10. The potential application of ribozymes for the treatment of hematological disorders. James HA J Leukoc Biol; 1999 Sep; 66(3):361-8. PubMed ID: 10496304 [TBL] [Abstract][Full Text] [Related]
11. 10th International Conference on gene therapy of cancer: 13 - 15 December 2001, San Diego, CA, USA. Chen Y Expert Opin Biol Ther; 2002 Apr; 2(4):443-5. PubMed ID: 11955281 [TBL] [Abstract][Full Text] [Related]
12. [Development of antisense nucleotides for therapy]. Wang J; Wang L; Wang Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):230-4. PubMed ID: 16532848 [TBL] [Abstract][Full Text] [Related]
13. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Phillips MI Hypertension; 1997 Jan; 29(1 Pt 2):177-87. PubMed ID: 9039099 [TBL] [Abstract][Full Text] [Related]
14. Antisense approaches to cancer gene therapy. Mercola D; Cohen JS Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254 [TBL] [Abstract][Full Text] [Related]
15. Ribozymes in the age of molecular therapeutics. Bagheri S; Kashani-Sabet M Curr Mol Med; 2004 Aug; 4(5):489-506. PubMed ID: 15267221 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential and mechanism of action of oligonucleotides and ribozymes. Lavrovsky Y; Chen S; Roy AK Biochem Mol Med; 1997 Oct; 62(1):11-22. PubMed ID: 9367793 [TBL] [Abstract][Full Text] [Related]
17. Utility of antioncogene ribozymes and antisense oligonucleotides in reversing drug resistance. Funato T Methods Mol Med; 2005; 106():215-33. PubMed ID: 15375319 [No Abstract] [Full Text] [Related]
18. Antisense technology for cancer therapy: does it make sense? Carter G; Lemoine NR Br J Cancer; 1993 May; 67(5):869-76. PubMed ID: 8494718 [No Abstract] [Full Text] [Related]
19. A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets. Yau EH; Butler MC; Sullivan JM Exp Eye Res; 2016 Oct; 151():236-55. PubMed ID: 27233447 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic applications of antisense oligonucleotides in asthma and allergy. Isidoro-García M; Dávila I Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):171-5. PubMed ID: 19075979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]